This report was first published by Endpoints News. To see the original version, click here
Private jets belonging to six of the largest US drugmakers landed at Washington, DC-area airports at least 127 times through September, according to an Endpoints News analysis, during one of the highest-stakes political situations for the industry in decades.
That adds up to a private plane from one of the companies landing in Washington almost every other day. The trips come at a time of near-constant lobbying and negotiation by the industry over drug prices, trade, science, the FDA and many other issues.
您已閱讀8%（600字），剩余92%（7274字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。